The game seems to continue...lots of other stocks getting hammered, but Conti just floats within the 10.5 -11.0 range, because thats where someone wants it?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%